Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression
Journal of Cardiothoracic Surgery · 2024
DOI: 10.1186/s13019-024-03075-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiothoracic Surgery, 2024. Verfasst von Yuan Shen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Huzhou Jiaotong Hospital, Huzhou, 313000, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, RNA, Circular, Lung Neoplasms, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: This report investigated the expression, prognostic and biological implications of hsa_circ_0079929 in lung adenocarcinoma, which was based on clinical and experimental data. METHODS: Patients with lung adenocarcinoma were screened and their clinical data and tissues (including cancerous tissues and adjacent normal tissues) were collected. The total RNA in tissues and cell lines was analyzed to obtained hsa_circ_0079929 level. The clinical significance was examined using the Chi-square test, Multi-variate Cox proportional hazards regression, and Kaplan-Meier curve. Cell malignant features were evaluated from three aspects (proliferation, migration, and invasion), detected by CCK-8 and Transwell methods. RESULTS: Hsa_circ_0079929 raised in expression level in lung adenocarcinoma. This upregulation of hsa_circ_0079929 was correlated with adverse clinical parameters and poor outcome in terms of overall survival, resulting in an independent prognostic purpose molecular for overall survival. Overexpression of hsa_circ_0079929 could contribute to cell proliferation/migration/invasion, whereas its knockdown could inhibit these malignant features. Hsa_circ_0079929 was a molecular decoy for miR-1184 in lung adenocarcinoma cells. CONCLUSIONS: Hsa_circ_0079929 could promote the malignant features of lung adenocarcinoma cells and may aid the follow up and therapeutic target discovery of lung adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Huzhou Jiaotong Hospital, Huzhou, 313000, China.
- Department of Oncology, Yuhuan Second People's Hospital, Yuhuan, 317605, China.
- Department of Respiratory Medicine, Traditional Chinese Medical Hospital of Zhuji, Zhuji, 311800, China.
- Department of Respiratory and Critical Care Medicine, Binhai County People's Hospital, No. 299, Haibin Avenue, Binhai County, Yancheng, 224500, China. Drmaojing299@163.com.
Zitieren
APA
Shen, Y., Han, R., Yu, X., & Mao, J. (2024). Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression. Journal of Cardiothoracic Surgery. https://doi.org/10.1186/s13019-024-03075-1
Vancouver
Shen Y, Han R, Yu X, Mao J. Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression. Journal of Cardiothoracic Surgery. 2024. doi:10.1186/s13019-024-03075-1
BibTeX
@article{Shen2024,
author = {Shen, Yuan and Han, Ruixue and Yu, Xin and Mao, Jing},
title = {Hsa_circ_0079929 in lung adenocarcinoma and its biological implications in lung adenocarcinoma progression},
journal = {Journal of Cardiothoracic Surgery},
year = {2024},
doi = {10.1186/s13019-024-03075-1}
}
EUVIMED